The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome
PHASE4CompletedINTERVENTIONAL
Enrollment
40
Participants
Timeline
Start Date
May 31, 2006
Study Completion Date
December 31, 2006
Conditions
Metabolic Syndrome
Interventions
DRUG
Pioglitazone, Rosiglitazone
Trial Locations (1)
136-705
Korea University Anam Hospital, Seoul
All Listed Sponsors
lead
Korea University Anam Hospital
OTHER
NCT00314561 - The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic Syndrome | Biotech Hunter | Biotech Hunter